載入...
Prognostic importance of CDK4/6-specific activity as a predictive marker for recurrence in patients with endometrial cancer, with or without adjuvant chemotherapy
BACKGROUND: Pathologically low-risk endometrial cancer patients do not receive postoperative treatment; however, 10–15% of these patients show recurrence with poor prognosis. We evaluated the clinical importance of cyclin-dependent kinase 4/6 (CDK4/6) activity, and its significance as a novel biomar...
Na minha lista:
發表在: | Br J Cancer |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
Nature Publishing Group
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4815892/ https://ncbi.nlm.nih.gov/pubmed/26554657 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2015.369 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|